semaglutide and ischemic colitis Colonic Ischemia Following Use: A Case Report | SN Comprehensive Clinical Medicine Tirzepatide-Associated Colonic Ischemia - PMC

It is the most-recently developed molecule in the GLP receptor agonist class and is supplied strictly for Research Use Only

We've done the research, so you don't have to

Of greater concern are potential risks from combination use: Hypoglycaemia risk: Retatrutide enhances insulin secretion in a glucose-dependent manner, which carries a low intrinsic hypoglycaemia risk when used alone

In addition, GLP-1R agonists help treat diabetes by protecting the brain and heart, preserving kidney function and aiding weight loss (Abiola et al., 2024)

E., Hodson D

Peters BT, Miller CA, Brady RA, Richards JT, Mulavara AP, Bloomberg JJ